Racism in Diabetes Care: The Hidden History

The history of diabetes care is not only a story of medical discovery and treatment progress. It is also a story of unequal treatment, exclusion, and racial bias that shaped who received care, who was believed, and who benefited from advances in medicine. Understanding racism in diabetes care helps explain why diabetes outcomes have long differed across racial and ethnic groups—and why those gaps still matter today.

At its core, racism in diabetes care has influenced diagnosis, treatment access, research priorities, and patient trust. For many communities, especially Black, Indigenous, Latino, and other marginalized groups, diabetes care has often been shaped by unequal systems rather than equal medical attention.

What Is Racism in Diabetes Care?

Racism in Diabetes Care refers to the often overlooked ways racial discrimination affected diabetes research, diagnosis, treatment, and public health policy over time. This racism was not always overt. In many cases, it appeared as:

• Exclusion from clinical research
• Biased medical assumptions
• Unequal access to insulin and diabetes education
• Delayed diagnosis or undertreatment
• Stereotypes about pain, compliance, or lifestyle
• Policies that ignored social and economic barriers to care

These patterns shaped not just individual patient experiences but the broader structure of diabetes care in the United States and beyond. Even today, discussions about racism in diabetes care often begin with these long-standing patterns of exclusion and bias.

Why This History Matters

Diabetes is one of the most common chronic diseases in the world. But people do not experience diabetes equally. Racial and ethnic minority populations have often had higher rates of diabetes complications, hospitalizations, and barriers to treatment.

This is not because of biology alone. It is also because of:

• Unequal access to healthy food, safe housing, and preventive care
• Lower rates of insurance coverage in some communities
• Mistrust of healthcare systems due to past abuse and neglect
• Bias in clinical decision-making
• Public health systems that have not adequately addressed structural racism

To understand diabetes disparities today, it is important to understand how those inequities were built over time. Racism in diabetes care did not begin with one policy or one study; it developed through generations of unequal access, unequal assumptions, and unequal outcomes. For readers interested in how lived experience and access barriers continue to shape care, the story Diabetes story: Raelynn Opens Up About Diabetes and Daily Life offers a helpful personal perspective.

Early Diabetes Care and Racial Exclusion

Early diabetes research and treatment were heavily shaped by the social and racial inequalities of their time. In the early 20th century, access to medical care was limited for many nonwhite patients. Hospitals, clinics, and research institutions often served segregated populations or excluded them entirely.

This meant that much of the early understanding of diabetes was based on white, middle- or upper-class patients. As a result, medical knowledge developed without fully representing the experiences of everyone affected by the disease.

That exclusion mattered. When medical evidence is built from a narrow group, the resulting standards can fail to reflect the needs of broader populations. In the history of racism in diabetes care, this kind of exclusion helped shape what doctors thought they knew, and it narrowed the range of patients whose experiences counted in medical progress.

Segregated Healthcare and Unequal Access to Insulin

The discovery of insulin in the 1920s transformed diabetes care. But access to that life-saving treatment was not equal.

In racially segregated healthcare systems, Black patients and other marginalized groups often received delayed, limited, or lower-quality care. Even when insulin became available, access depended on money, location, and whether a patient could enter a facility that offered consistent diabetes treatment.

This created a painful gap between medical progress and real-world access. A breakthrough treatment meant little if entire communities were left out of the systems that delivered it. Racism in diabetes care was visible not only in who received insulin, but also in who was allowed to benefit from new medical advances. For an example of how modern diabetes tools can change care when access improves, see Companion Medical InPen Launched: What It Means for Diabetes Care.

Bias in Medical Beliefs About Black Patients and Diabetes

One of the most damaging aspects of racism in diabetes care has been the way medical professionals have sometimes misunderstood or stereotyped Black patients.

For decades, some clinicians and researchers wrongly assumed that Black people were less likely to follow treatment recommendations, less likely to report symptoms accurately, or less engaged in self-care. These assumptions could lead to:

• Less aggressive treatment
• Fewer referrals to specialists
• Inadequate education about diabetes management
• Reduced trust between patient and provider

These stereotypes were not based on science. They reflected racial bias and structural inequality. When healthcare providers interpret social barriers as personal failure, patients suffer. In practice, racism in diabetes care can turn a treatable condition into a much harder one to manage.

How Research Exclusion Shaped Diabetes Guidelines

Clinical research is supposed to produce evidence-based care. But if the people in that research do not represent the full population, the evidence can be incomplete or skewed.

Historically, many diabetes studies underrepresented Black, Latino, Indigenous, and other minority groups. This led to gaps in knowledge about:

• How diabetes progresses in different populations
• How medications work across diverse groups
• Which care strategies are most effective in underserved communities
• How social determinants of health affect diabetes management

When research does not include enough diverse voices, treatment guidelines may be less effective or harder to apply fairly. This is one reason why inclusive research is so important in modern healthcare. In the context of racism in diabetes care, representation in studies is not a side issue; it is part of making treatment safer and more accurate for everyone. If you want to read more about current scientific progress, the CDC’s diabetes resources provide a reliable overview of prevention, treatment, and public health guidance.

Race-Based Medical Ideas and the Problem of Biology Shortcuts

Another hidden form of racism in diabetes care has been the use of race as a biological shortcut. Medicine has often treated race as if it were a clear genetic category, when in reality race is a social construct shaped by history, power, and inequality.

In diabetes care, race-based thinking has sometimes led to misleading conclusions. For example, differences in diabetes outcomes have been attributed to genetics when social conditions, access to care, and stress from discrimination may play a larger role.

This matters because when healthcare systems focus too narrowly on race as biology, they may overlook the true causes of disease disparities. That can delay better solutions, such as improving access to care, reducing poverty, and addressing neighborhood-level health risks. A fuller view of racism in diabetes care requires looking beyond labels and examining how social systems influence health.

For some patients, the effects of bias are especially visible when treatment plans fail to match real daily routines. The rise of better diabetes technology, such as smarter insulin delivery support, shows how care can improve when systems respond to lived experience rather than assumptions. That is one reason conversations about diabetes equity should include newer tools alongside older public health lessons.

Misdiagnosis and Delayed Diagnosis in Minority Communities

Racism in Diabetes Care has also influenced diagnosis. Some patients from marginalized groups have been diagnosed later than they should have been or received less thorough testing.

This can happen when symptoms are dismissed, risk is underestimated, or providers assume a patient’s problems are caused by poor behavior rather than a medical condition. Delayed diagnosis means higher blood sugar levels for longer periods, which increases the risk of complications such as:

• Vision loss
• Kidney disease
• Nerve damage
• Heart disease
• Stroke

Early diagnosis is essential in diabetes care. When bias delays diagnosis, the consequences can be lifelong. This is one of the clearest ways racism in diabetes care harms patients before treatment even begins.

Misdiagnosis can also happen when clinicians rely too heavily on stereotypes rather than testing and follow-up. A patient’s age, neighborhood, insurance status, or language should never replace basic clinical judgment. Yet in unequal systems, these details can shape whether symptoms are taken seriously. That is why the history of diabetes care is also a history of who is believed, who is monitored, and who is sent home without the help they need.

The Burden of Diabetes Education Inequity

Good diabetes care requires more than prescriptions. It requires education, support, and practical tools for day-to-day management. Yet diabetes education has not always been accessible or culturally responsive.

Historically, educational materials and programs were often designed around white, English-speaking, middle-class patients. That left many communities without resources that reflected their language, dietary traditions, work schedules, or family structures.

For example, advice about diet and exercise may sound simple in theory but may not be realistic for someone living in a food desert, working multiple jobs, or lacking safe spaces for physical activity. When care plans ignore those realities, patients may be unfairly labeled noncompliant instead of unsupported.

This gap is one reason advocates continue to push for a more individualized, equitable model of diabetes care, including better education about devices, medications, and daily routines. Racism in diabetes care also shows up when patient education is offered in a one-size-fits-all way that leaves some communities behind. In some cases, that includes practical tools such as bolus dosing support, as discussed in Bolus insulin: Bolus Blues: Brendan McEachern’s Diabetes Guide.

Education equity also means using plain language, translated materials, and teaching methods that respect different learning styles. It means recognizing that a patient may need more than information—they may need transportation, flexible appointment times, culturally familiar meal planning, and device training that fits real life. Without those supports, even the best medical advice can be hard to use.

Structural Racism and Diabetes Outcomes

The hidden racism in diabetes care is closely tied to structural racism, which refers to systems and policies that create and maintain racial inequality.

In diabetes care, structural racism can affect:

• Insurance coverage
• Transportation to appointments
• Availability of specialty care
• Neighborhood access to healthy foods
• Exposure to chronic stress
• Environmental risks that worsen health

These factors do not operate in isolation. They interact over time, increasing the risk of poor diabetes control and complications. This is why diabetes disparities cannot be solved by telling individuals to “try harder.” The problem is bigger than individual behavior, and racism in diabetes care must be addressed at the level of policy, systems, and community support.

Structural racism also affects the time patients can spend with providers. Short visits, high out-of-pocket costs, and repeated insurance barriers can all make diabetes management more difficult. If a patient cannot afford supplies, cannot get time off work, or cannot reach a pharmacy reliably, then the system itself is part of the health problem. That is why diabetes equity requires both clinical care and social support.

Medical Mistrust and Its Historical Roots

Many communities of color have deep mistrust of the healthcare system, and that mistrust has historical reasons. Racist treatment, exploitation, neglect, and unequal care have damaged trust across generations.

In diabetes care, mistrust may lead some patients to delay seeking care, avoid tests, or feel less confident in medical advice. While this can be frustrating for providers, it is important to recognize that mistrust is often a rational response to historical harm.

Building trust requires more than awareness. It requires respectful communication, accountability, representation, and consistent equitable care. Confronting racism in diabetes care also means acknowledging why some patients arrive at the clinic with understandable caution.

Trust improves when people are listened to, given clear explanations, and treated as partners in decision-making. It also improves when communities see the healthcare system showing up consistently outside the exam room through outreach, screening, and local partnerships. These efforts are not cosmetic; they are part of repairing harm.

Progress Has Been Made, but Inequities Remain

There has been progress in diabetes care. Awareness of health disparities has grown, more researchers are studying social determinants of health, and some healthcare systems are working to improve equity. More diverse voices are also influencing medical education and public health.

Still, disparities remain. Many communities continue to face higher rates of diabetes complications and less access to high-quality treatment. The legacy of racism is still visible in:

• Underdiagnosis
• Unequal treatment outcomes
• Limited access to specialists and technology
• Lower participation in research
• Persistent gaps in education and support

Progress requires more than acknowledging the problem. It requires changing the systems that created it. If racism in diabetes care is to be reduced in any lasting way, health systems must measure outcomes honestly and respond to the communities most affected.

That includes asking hard questions about who gets referrals, who gets follow-up, who receives newer technologies, and who is left out of quality improvement efforts. It also means using data to identify patterns of inequity instead of assuming that unequal outcomes are inevitable. When disparities are measured carefully, they become easier to address.

What Patients and Families Should Know

If you or a loved one has diabetes, it is important to know that unequal care is not your fault. Historical racism and structural barriers have shaped many of the challenges people face.

Patients can advocate for themselves by:

• Asking questions about test results and treatment options
• Requesting culturally appropriate diabetes education
• Seeking care from providers who listen and explain clearly
• Bringing a trusted family member or advocate to appointments
• Asking whether community programs, social workers, or diabetes educators are available

At the same time, the burden should not fall only on patients. Healthcare systems must do more to ensure fair, respectful, and effective care for everyone. That is especially important in conversations about racism in diabetes care, where the focus should be on improving systems rather than blaming individuals.

Families can also help by tracking blood sugar patterns, writing down questions before appointments, and helping patients understand what the care plan is asking them to do. Small forms of support can make a big difference when navigating complex medical systems. But again, those supports should complement, not replace, better care from institutions.

How Healthcare Systems Can Address Racism in Diabetes Care

Reducing racism in diabetes care requires action at every level. Important steps include:

• Expanding access to affordable insulin and medications
• Improving insurance coverage and preventive services
• Increasing diversity in research studies and medical leadership
• Training clinicians to recognize bias and structural inequity
• Developing culturally responsive diabetes education
• Supporting community-based health programs
• Collecting and analyzing outcome data by race and ethnicity
• Addressing social needs such as food insecurity and transportation

These changes can help make diabetes care more equitable and effective. They also move the conversation about racism in diabetes care from awareness alone to measurable action.

Healthcare organizations can also improve by hiring and retaining a more diverse workforce, partnering with community leaders, and making room for patient feedback in quality improvement. Equity is not achieved by a single training session. It comes from repeated, measurable changes in policy, staffing, communication, and access.

Frequently Asked Questions

Is diabetes caused by race?

No. Diabetes is not caused by race. Race is not a biological cause of diabetes. However, racial inequities, including stress, access barriers, and unequal care, can affect diabetes risk and outcomes.

Why are diabetes outcomes worse in some racial groups?

Worse outcomes are often linked to structural factors such as poverty, lack of access to care, food insecurity, discrimination, and under-resourced communities—not inherent biological differences.

Was insulin care always available to everyone?

No. Even after insulin was discovered, access was unequal. Segregation, cost, and healthcare discrimination limited who could receive timely treatment.

How did racism affect diabetes research?

Racism affected who was included in studies, how results were interpreted, and whether treatment guidelines reflected the needs of all populations.

Can bias still affect diabetes treatment today?

Yes. Bias can still influence diagnosis, prescribing decisions, communication, and how seriously symptoms are taken.

The Bigger Lesson From Diabetes Care History

The hidden racism in diabetes care shows that medicine does not happen in a vacuum. Scientific advances can save lives, but only when they are delivered through fair systems. If care is unequal, the benefits of medicine are unequal too.

A more honest history of diabetes care does not diminish medical progress. It makes progress more meaningful by showing what still needs to change. Recognizing racism in diabetes care is a necessary step toward building a future where diabetes care is truly equitable for all.

The lesson is clear: to improve diabetes outcomes, healthcare systems must confront racism in diabetes care directly, support patients with practical resources, and keep pushing for access, accountability, and dignity in every setting.

That means listening to patient experiences, improving representation in research, and making sure every community receives timely, respectful, evidence-based care. Only then can diabetes care become both medically advanced and genuinely just.

One practical step for readers who want to understand the broader field is to review trusted public health guidance and compare it with community experiences. That contrast often makes the gaps in care easier to see. The history is painful, but it is also useful: once the pattern is visible, it becomes harder to ignore and easier to change.

In the end, confronting racism in diabetes care is not about assigning blame to patients or denying medical progress. It is about telling the full story so the next chapter can be fairer, smarter, and more humane.